In addition, we found higher DNAm-based estimates of plasma levels for CXCL10, CXCL11, enRAGE, signature of chronic low-grade inflammation and surrogate of exhausted CD8 + T cell counts in non-survivor T2D patients. The gene discussed is CXCL11; the disease is type 2 diabetes mellitus.